NCT00302003 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Treatment consists of 3 cycles of Doxorubicin hydrochloride IV (25 mg/m2) days 1 \& 2, Vincristine sulfate IV (1.4 mg/m2 \[max 2.8 mg\]) Days 1 \& 8, Prednisone orally (40 mg/m2) Days 1-7, Cyclophosphamide IV (600 mg/m2) Days 1 \& 2, Filgrastim by mouth or IV (5 micrograms/kg/dose) 24 hours after Cyclophosphamide complete. See detailed description for remainder of therapy. radiation therapy: Undergo radiation therapy doxorubicin hydrochloride: Given IV vincristine sulfate: Given IV prednisone: Given orally cyclophosphamide: Given IV ifosfamide: Given IV vinorelbine tartrate: Given IV dexamethasone: Given IV etoposide phosphate: Given IV cisplatin: Given IV cytarabine: Given IV filgrastim: Given IV or subcutaneously
- id
- FG000
- title
- Doxorubicin, Vincristine, Cyclophosphamide and Filgrastim
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 62
- type
- Lack of Efficacy
- reasons
- group Id
- FG000
- num Subjects
- 1
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 2
- type
- Physician Decision
- reasons
- group Id
- FG000
- num Subjects
- 5
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 9
- type
- Ineligible
- reasons
- group Id
- FG000
- num Subjects
- 1
- type
- Protocol Violation
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 287
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 207
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 80
- type
- NOT COMPLETED
- title
- Overall Study
Complete source fields
- groups
- description
- Treatment consists of 3 cycles of Doxorubicin hydrochloride IV (25 mg/m2) days 1 \& 2, Vincristine sulfate IV (1.4 mg/m2 \[max 2.8 mg\]) Days 1 \& 8, Prednisone orally (40 mg/m2) Days 1-7, Cyclophosphamide IV (600 mg/m2) Days 1 \& 2, Filgrastim by mouth or IV (5 micrograms/kg/dose) 24 hours after Cyclophosphamide complete. See detailed description for remainder of therapy. radiation therapy: Undergo radiation therapy doxorubicin hydrochloride: Given IV vincristine sulfate: Given IV prednisone: Given orally cyclophosphamide: Given IV ifosfamide: Given IV vinorelbine tartrate: Given IV dexamethasone: Given IV etoposide phosphate: Given IV cisplatin: Given IV cytarabine: Given IV filgrastim: Given IV or subcutaneously
- id
- FG000
- title
- Doxorubicin, Vincristine, Cyclophosphamide and Filgrastim
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 62
- type
- Lack of Efficacy
- reasons
- group Id
- FG000
- num Subjects
- 1
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 2
- type
- Physician Decision
- reasons
- group Id
- FG000
- num Subjects
- 5
- type
- Withdrawal by Subject
- reasons
- group Id
- FG000
- num Subjects
- 9
- type
- Ineligible
- reasons
- group Id
- FG000
- num Subjects
- 1
- type
- Protocol Violation
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 287
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 207
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 80
- type
- NOT COMPLETED
- title
- Overall Study
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle